NeuroPointDX Announces Confirmation of First-Generation Autism Diagnostic Panel
NeuroPointDX has validated 12 metabolic subtypes of autism spectrum disorder. The diagnostic blood test for ASD will be
Read moreNews
News
Stemina Featured as an Innovative Madison-Area Business
September 27, 2017
In collaboration with the Greater Madison Chamber of Commerce, the Wisconsin State Journal produced a special section to
Read moreStemina Biomarker Discovery Prepares to Commercialize Autism Diagnostic Products; Appoints New Board Member, Heiner Dreismann, PhD, Former Head of Roche Molecular Diagnostics
August 25, 2017
Dr. Driesmann, a leader in the diagnostics industry, will guide Stemina’s commercialization strategy. Read the full press release.
Read moreMetabolic Profiling of the Children’s Autism Metabolome Project (CAMP) – IMFAR 2017 [PDF]
May 15, 2017
Metabolic Profiling of the Children’s Autism Metabolome Project (CAMP) NeuroPointDX is conducting a research study called Children’s Autism
Read moreNeuroPointDX Partners with Ovid Therapeutics to Identify Biomarkers for Angelman Syndrome
February 9, 2017
Together, Ovid and NeuroPointDX will use metabolomics data to better understand the rare neuro-genetic disorder known as Angelman
Read moreNeuropoint CEO Beth Donley to deliver welcome remarks at 64th Annual Chamber Dinner
September 27, 2016
Stemina’s CEO, Beth Donley, will deliver the welcome remarks at the 64th Annual Greater Madison Chamber of Commerce
Read moreNeuroPoint to Present Poster at IMFAR 2016
May 12, 2016
The International Meeting for Autism Research (IMFAR) will be held in Baltimore, Maryland May 11-14. Visit the Saturday
Read moreAutism Blood Test on Horizon
February 26, 2016
A University of Wisconsin—Madison spinoff is screening blood samples in an effort to develop a biologically based method
Read moreDonley Named InBusiness Exec of the Year
February 18, 2016
Stemina’s CEO, Beth Donley, is named Executive of the Year by Madison’s InBusiness Magazine. Read the Article
Read moreStemina Launches Large Autism Diagnostic Study
September 24, 2015
With a new $2.7 million federal grant in hand, Stemina Biomarker Discovery has launched a 1,500-patient study of
Read more- 1
- 2
